What is NDC 71335-9607?

71335-9607 is the product NDC for terazosin, Terazosin hydrochloride 10 mg/1 capsule, listed with the FDA by Bryant Ranch Prepack. It has 3 package NDCs, shown above in 10- and 11-digit form.

Bryant Ranch Prepack, NDC labeler code 71335. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for terazosin?

61 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

terazosin NDC 71335-9607 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)71335-9607Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71335-9607Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
71335-9607-1	7133596070171335960701	30 CAPSULE in 1 BOTTLE (71335-9607-1)Marketed from Dec 20, 2022
71335-9607-2	7133596070271335960702	28 CAPSULE in 1 BOTTLE (71335-9607-2)Marketed from Dec 20, 2022
71335-9607-3	7133596070371335960703	90 CAPSULE in 1 BOTTLE (71335-9607-3)Marketed from Dec 20, 2022

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): terazosin
Generic name (nonproprietary): terazosin
Active ingredients: Terazosin hydrochloride — 10 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Bryant Ranch PrepackNDC labeler code 71335
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 075614
Marketing start: Apr 30, 2021
Listing expires: Dec 31, 2026
Other FDA classes: Adrenergic alpha-Antagonists (Mechanism)
Identifiers: Product ID 71335-9607_ff1d7383-5600-487f-b66e-4c2eef397eafSPL ID ff1d7383-5600-487f-b66e-4c2eef397eafSPL set ID 2cdbb03d-0ac9-477b-88f6-5d9492277048RxCUI 260376UNII D32S14F082
Pharmacologic class: alpha-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471335960701 followed by a unit qualifier and the quantity

Package 71335-9607-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 27, 2023.

Indications (excerpt from the label)

INDICATIONS AND USAGE Terazosin capsules are indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH). There is a rapid response, with approximately 70% of patients experiencing an increase in urinary flow and improvement in symptoms of BPH when treated with terazosin. The long term effects of terazosin on the incidence of surgery, acute urinary obstruction or other complications of BPH are yet to be determined. Terazosin capsules are also indicated for the treatment of hypertension. They can be used alone or in combination with other antihypertensive agents such as diuretics or beta-adrenergic blocking agents.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 71335-9607

What is NDC 71335-9607?: 71335-9607 is the product NDC for terazosin, Terazosin hydrochloride 10 mg/1 capsule, listed with the FDA by Bryant Ranch Prepack. It has 3 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: terazosin.
What is the active ingredient?: Terazosin hydrochloride.
Who is the labeler?: Bryant Ranch Prepack, NDC labeler code 71335. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for terazosin?: 61 other product NDCs are listed under this name. See all terazosin NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other terazosin NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Terazosin	Terazosin hydrochloride 2 mg/1	CapsuleOral	Preferred Pharmaceuticals Inc.	68788-4064	68788-4064-0168788-4064-03
Terazosin	Terazosin hydrochloride 2 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-4545	70518-4545-00
Terazosinterazosin hydrochloride	Terazosin hydrochloride 5 mg/1	CapsuleOral	Coupler LLC	67046-1622	67046-1622-03
Terazosin	Terazosin hydrochloride 1 mg/1	CapsuleOral	Ajanta Pharma USA Inc.	27241-288	27241-0288-0127241-0288-10
Terazosin	Terazosin hydrochloride 2 mg/1	CapsuleOral	Ajanta Pharma USA Inc.	27241-289	27241-0289-0127241-0289-10
Terazosin	Terazosin hydrochloride 5 mg/1	CapsuleOral	Ajanta Pharma USA Inc.	27241-290	27241-0290-0127241-0290-10
Terazosin	Terazosin hydrochloride 10 mg/1	CapsuleOral	Ajanta Pharma USA Inc.	27241-291	27241-0291-0127241-0291-10
Terazosin	Terazosin hydrochloride 1 mg/1	CapsuleOral	Bionpharma Inc.	69452-330	69452-0330-2069452-0330-32
Terazosin	Terazosin hydrochloride 2 mg/1	CapsuleOral	Bionpharma Inc.	69452-331	69452-0331-2069452-0331-32
Terazosin	Terazosin hydrochloride 5 mg/1	CapsuleOral	Bionpharma Inc.	69452-332	69452-0332-2069452-0332-32

All 62 terazosin NDCs

Other NDCs under ANDA 075614

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 075614
Product	Strength	Form · route	Labeler	Product NDC
terazosin	Terazosin hydrochloride 1 mg/1	CapsuleOral	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	23155-735
terazosin	Terazosin hydrochloride 2 mg/1	CapsuleOral	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	23155-736
terazosin	Terazosin hydrochloride 5 mg/1	CapsuleOral	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	23155-737
terazosin	Terazosin hydrochloride 10 mg/1	CapsuleOral	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	23155-738
terazosin	Terazosin hydrochloride 1 mg/1	CapsuleOral	A-S Medication Solutions	50090-7851
terazosin	Terazosin hydrochloride 2 mg/1	CapsuleOral	Northwind Health Company, LLC	51655-915
terazosin	Terazosin hydrochloride 1 mg/1	CapsuleOral	Aphena Pharma Solutions - Tennessee, LLC	53401-022
Terazosin	Terazosin hydrochloride 1 mg/1	CapsuleOral	Chartwell RX, LLC	62135-458
Terazosin	Terazosin hydrochloride 2 mg/1	CapsuleOral	Chartwell RX, LLC	62135-459
Terazosin	Terazosin hydrochloride 5 mg/1	CapsuleOral	Chartwell RX, LLC	62135-460
Terazosin	Terazosin hydrochloride 10 mg/1	CapsuleOral	Chartwell RX, LLC	62135-461
terazosin	Terazosin hydrochloride 2 mg/1	CapsuleOral	Preferred Pharmaceuticals Inc.	68788-8171
terazosin	Terazosin hydrochloride 1 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-3193